Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)

Gabriella Macchia; Barbara Alicja Jereczek-Fossa; Roberta Lazzari; Annamaria Cerrotta; Francesco Deodato; Edy Ippolito; Cynthia Aristei; Maria Antonietta Gambacorta; Giovanni Scambia; Vincenzo Valentini; Gabriella Ferrandina

doi:10.1136/ijgc-2021-002709

Article metrics

other Versions

You are currently viewing an earlier version of this article (June 21, 2021).
View the most recent version of this article

Clinical trial

Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)

Online download statistics by month:

Online download statistics by month: June 2021 to December 2023

	Abstract	Full	Pdf
Jun 2021	70	56	52
Jul 2021	43	17	8
Aug 2021	18	5	2
Sep 2021	17	13	13
Oct 2021	205	6	5
Nov 2021	247	6	7
Dec 2021	125	4	3
Jan 2022	207	7	8
Feb 2022	503	13	13
Mar 2022	176	5	6
Apr 2022	186	5	5
May 2022	157	7	5
Jun 2022	170	9	9
Jul 2022	565	24	10
Aug 2022	279	12	12
Sep 2022	263	5	5
Oct 2022	281	10	3
Nov 2022	334	9	8
Dec 2022	114	5	3
Jan 2023	220	2	3
Feb 2023	135	6	7
Mar 2023	121	5	2
Apr 2023	96	2	2
May 2023	120	5	3
Jun 2023	106	7	8
Jul 2023	91	8	6
Aug 2023	154	12	9
Sep 2023	87	4	4
Oct 2023	108	0	0
Nov 2023	90	4	4
Dec 2023	23	0	0
Total	5311	273	225

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Online download statistics by month:

Online download statistics by month: June 2021 to December 2023

Read the full text or download the PDF:

Log in using your username and password